Exposure to polycyclic aromatic hydrocarbons and newborn biometric indicators

Area of Science:

• Environmental Health
• Reproductive Toxicology
• Pediatrics

Background:

• Polycyclic aromatic hydrocarbons (PAH) are environmental pollutants linked to adverse health outcomes.
• Prenatal exposure to environmental toxins can significantly impact fetal development.
• Identifying sources of PAH exposure during pregnancy is crucial for public health.

Purpose of the Study:

• To investigate the association between prenatal exposure to polycyclic aromatic hydrocarbons (PAH) and fetal growth parameters.
• To assess the role of active and passive smoking as a source of PAH exposure in pregnant women.

Main Methods:

• Prospective cohort study involving 449 mother-child pairs in Poland.
• Biomarker for PAH exposure: 1-hydroxypyrene (1-HP) in urine, measured via HPLC.
• Assessment of smoking exposure using saliva cotinine levels via LC-ESI+MS/MS.

Main Results:

• PAH exposure, measured by 1-HP, was significantly associated with lower birth weight, chest circumference, and cephalisation index.
• These associations remained significant after adjusting for multiple confounding factors.
• After controlling for active and passive smoking (cotinine levels), the statistical significance of PAH associations with fetal growth was lost.

Conclusions:

• Prenatal PAH exposure can adversely affect fetal development, including birth weight and circumference.
• Tobacco smoking is a significant source of PAH exposure.
• The observed negative impacts of PAH on fetal growth may be largely explained by concurrent tobacco smoke exposure.